Forian Inc ( (FORA) ) has released its Q1 earnings. Here is a breakdown of the information Forian Inc presented to its investors.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Forian Inc. is a prominent provider of data science-driven information and analytics solutions, catering to the life sciences, healthcare, and financial services sectors. The company is known for its expertise in managing and commercializing large-scale healthcare data assets.
In its first quarter of 2025, Forian Inc. reported a significant increase in revenue, marking a 45% rise compared to the previous year. This growth is attributed to strategic acquisitions, contract renewals, and the integration of new data feeds, despite the ongoing macroeconomic uncertainties.
Key financial highlights include a revenue of $7.1 million, up from $4.9 million in the same quarter last year, and a net loss of $1.1 million, slightly improved from the previous year’s $1.2 million. The company’s adjusted EBITDA showed a decline, reflecting increased investments and integration costs. Forian also expanded its presence in the pharmaceutical sector, benefiting from the adoption of its data solutions.
Looking ahead, Forian Inc. anticipates its revenue for the full year 2025 to range between $28 million and $30 million, with adjusted EBITDA expected to be between ($1.0) million and $1.0 million. The company remains optimistic about expanding its market share and enhancing its impact across the healthcare industry.